Fintel reports that on November 3, 2025, BMO Capital upgraded their outlook for Replimune Group (NasdaqGS:REPL) from Underperform to Market Perform. As of October 30, 2025, the average one-year price ...

Despite a sharp drop in the previous session following the FDA rejection of its skin cancer drug RP1, Replimune (NASDAQ:REPL) shares bounced back on Wednesday even as multiple Wall Street analysts ...

Buy REPL near 10.13 target 12.89 stop loss @ 10.1 Details The technical summary data tells us to buy REPL near 10.13 with an upside target of 12.89. This data also tells us to set a stop loss @ 10.1 ...

Community driven content discussing all aspects of software development from DevOps to design patterns. Note, this article deals with client-side JavaScript. For a client and server-side JavaScript ...

Robbie has been an avid gamer for well over 20 years. During that time, he's watched countless franchises rise and fall. He's a big RPG fan but dabbles in a little bit of everything. Writing about ...

Functional programming, as the name implies, is about functions. While functions are part of just about every programming paradigm, including JavaScript, a functional programmer has unique ...

Visual Studio Code is a code editor that is completely free and open-source. It has been developed by Microsoft and is highly regarded by developers due to its lightweight, fast, and extensible design ...

Manufacturer of high-voltage switchgear and automation equipment announces creation of INERTIA-REPL to offer industry best of class power cable accessories serving electrical utility, construction and ...